Miami Jewish Health Systems — Miami, Florida

Miami Jewish Health Systems is a clinical research site located in Miami, Florida, United States 33137.

Crixeo Health Trust Score: 85/100 (GOOD). This profile has not yet been claimed by the site owner.

Miami Jewish Health Systems has participated in 33 clinical trials with 5 currently active.

Therapeutic areas: Alzheimer's Disease, Dementia of the Alzheimer's Type, Mild Cognitive Impairment.

Sponsors: Neuronix Ltd, Chase Pharmaceuticals Corporation, an affiliate of Allergan plc, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 85/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Miami Jewish Health Systems?

Miami Jewish Health Systems has a Crixeo Trust Score of 85/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Miami Jewish Health Systems conducted?

Miami Jewish Health Systems has 33 clinical trials on record, with 5 currently active. Their work covers Alzheimer's Disease, Dementia of the Alzheimer's Type, Mild Cognitive Impairment.

Is Miami Jewish Health Systems accredited by Crixeo Health?

Miami Jewish Health Systems has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Miami Jewish Health Systems?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.